To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Tolterodine is an antimuscarinic drug that is used to treat urinary incontinence. It is sold under the trade name Detrol.
Tolterodine, although it acts on two types of receptors, has fewer side effects than other antimuscarinics eg. oxybutynin (which is selective for M3 only) as tolterodine targets the bladder more than other areas of the body. This means that less drug needs to be given daily (due to efficient targeting of the bladder) and so there are fewer side effects.
Known Side Effects:
Reports of Patients’ Experiences Since Detrol Became Available:
The following reactions have been reported in patients who have taken Detrol since it has become available:
Contraindications Not to be used in patients with Myasthenia Gravis and Angle Closure Glaucoma
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Tolterodine". A list of authors is available in Wikipedia.|